Injective has been in the spotlight with varied events happening around it. There is a major prediction that
Injective's price might have the potential to take off after revealing a positive 30-D MVRV. The team also launched an Ethereum Virtual Machine (EVM) that promises faster and cheaper DeFi. Meanwhile, Pineapple Financial has added $2M to its treasury with
Injective, and now they are planning to migrate its $10B mortgage portfolio on-chain via this protocol.
Furthermore, significant moves have been taking place on the institutional front. Canary has updated the
Staked Injective ETF registration document with the SEC and, remarkably, 21Shares has applied for an ETF that includes INJ. These developments show a growing demand for fund products that involve altcoins. There's most notably been the first on-chain digital treasury SBET launch.
However, it hasn't all been roses, as
Injective's price saw a significant 3.9% drop with a wide-scale deleveraging event. Despite the market-wide downturn, though, there has been a lot of excitement for
Injective's future, especially considering the recent supply squeeze tokenomics shift and the introduction of Agora's AUSD as its first native stablecoin.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Sat, 21 Feb 2026 13:58:00 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor 5
